Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 31, 2015 3:03 AM ET

Biotechnology

Company Overview of GlycoVaxyn AG

Company Overview

GlycoVaxyn AG, a vaccine biopharmaceutical company, engages in the development and manufacture of next-generation bio-conjugate vaccines against bacterial infections utilizing its recombinant DNA technology. It develops and produces immunogenic glycoprotein conjugates vaccines for a range of bacterial diseases, such as pneumococcal and nosocomial infections. GlycoVaxyn AG was founded in 2004 and is based in Schlieren, Switzerland. As of February 11, 2015, GlycoVaxyn AG operates as a subsidiary of GlaxoSmithKline plc.

Grabenstrasse 3

Schlieren,  8952

Switzerland

Founded in 2004

Phone:

41 44 733 85 85

Fax:

41 44 733 85 74

Key Executives for GlycoVaxyn AG

Chief Executive Officer and Member of the Supervisory Board
Age: 52
Co-Founder and Chief Scientific Officer
Co-Founder and Head of Corporate Development
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Redbiotec AG Europe
Cardiorentis AG Europe
Qiagen AG Europe
Glaxo Institute for Molecular Biology Europe
CYPA Laboratoire de cytologie et de pathologie cliniques SA Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
February 11, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GlycoVaxyn AG, please visit www.glycovaxyn.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.